CA-125 Blood Test: Normal Range, High Levels & Ovarian Cancer

The CA-125 blood test measures cancer antigen 125, a protein best known as a tumor marker for ovarian cancer. But one point is essential and too often misunderstood: a high CA-125 is not a cancer diagnosis. In women, it rises very commonly for benign reasons — menstruation, pregnancy, endometriosis, uterine fibroids, ovarian cysts. Its most established use is monitoring an already-known ovarian cancer and, alongside imaging, helping evaluate a pelvic mass — not screening healthy women. This guide explains the normal range, what a high CA-125 means, and when (and when not) to worry. Like any tumor marker, the result is never read alone, and always interpreted by your clinician.

Key takeaways

• CA-125 is a protein made by cells lining the ovaries, peritoneum, pleura, and pericardium. It is a signal to interpret, not a diagnosis.¹²
• A common reference is CA-125 below ~35 U/mL. The cutoff varies by lab and assay, so compare against the range on your report.³²
• A high CA-125 most often has a benign cause in women: menstruation, pregnancy, endometriosis, ovarian cysts, uterine fibroids, pelvic inflammatory disease, and non-gynecologic causes like cirrhosis, ascites, or heart failure.⁴⁵⁶
• A mildly high CA-125 in a younger, premenopausal woman is very often not serious; the test is more reliable after menopause.²⁶
• To evaluate a pelvic mass, clinicians combine CA-125 with a second marker, HE4, in the ROMA score, alongside transvaginal ultrasound — never a marker alone.⁷⁸
• CA-125 is not a screening test. The large UK UKCTOCS trial found that screening with CA-125 (± ultrasound) did not reduce ovarian-cancer deaths.⁹

Normal CA-125 levels

Here is the commonly used reference in adults. It is indicative only: the cutoff and unit depend on the lab's assay, so rely on the range printed on your report.

Good to know: the 35 U/mL cutoff is the convention used for the ovarian-cancer question, but there is no standardized threshold for benign situations.² A value slightly above 35 is not alarming in itself, especially in a woman who is young, menstruating, or pregnant. What matters as much as the number is the context, the imaging, and — in a known cancer — the trend over time.

What is CA-125?

Cancer antigen 125 (CA-125), also called MUC16, is a large protein on the surface of certain cells. It is normally present in the serous membranes — the thin linings of the peritoneum (abdomen), pleura (lungs), and pericardium (heart) — and in the female reproductive tract. Whenever those tissues are irritated, stretched, or inflamed, they release more CA-125 into the blood.²⁵

That is exactly why the marker lacks specificity: CA-125 does rise in some cancers (mainly epithelial ovarian cancer), but also in many benign, common conditions in women. A high CA-125 is therefore a signal to interpret in context, never a diagnosis by itself. It belongs to no routine panel — it is a targeted test, ordered in specific situations.

What the CA-125 test is used for

A clinician may order CA-125 to:

• Monitor a known ovarian cancer — to follow how well treatment is working and to detect a recurrence. This is its main and best-validated use.¹¹⁰
• Help evaluate a pelvic (adnexal) mass found on ultrasound — often together with HE4 and the ROMA score — to estimate the risk it is malignant and guide referral to a gynecologic oncologist.⁷¹¹
• Less often, help investigate abdominal symptoms or ascites (fluid in the abdomen) whose cause is being sought.⁵

CA-125 is not a test to run "just to make sure there's no cancer." Used as screening in a woman without symptoms, it produces many false alarms without saving lives (see below).⁹³

Interpreting your results

High CA-125: think benign causes first

This is the result that worries people most — usually without cause. In women, a high CA-125 is most often benign.⁴⁵ The test is also less specific before menopause, when benign gynecologic conditions are common.² A moderately raised value in a younger woman with no suspicious mass on ultrasound points first toward these benign explanations.⁶⁵

Let's defuse a myth: "high CA-125 = ovarian cancer." That is false. Many women have a CA-125 above 35 with no cancer (endometriosis, cysts, menstruation, pregnancy), and some ovarian cancers — especially early ones — show a normal CA-125. In fact, CA-125 is elevated in only about half of early-stage ovarian cancers.² The marker neither confirms nor rules out cancer on its own: only imaging (ultrasound, MRI) and specialist assessment can settle it.⁴⁶

A normal CA-125

A CA-125 within the usual range is reassuring, but does not guarantee the absence of disease: some early ovarian cancers have a normal CA-125.² There is no such thing as a CA-125 that is "too low" — a low value is normal and carries no negative meaning.

"CA-125 over 50, 100, 200 — should I worry?"

There is no single number that signals cancer. In general, the higher the value, the more persistently it stays above the cutoff, and the more it comes with a suspicious mass or symptoms, the more it justifies further testing — without panic. Yet markedly high values are also seen in benign conditions (extensive endometriosis, ascites, pelvic infection). Conversely, a CA-125 a little above 35 that is stable with normal imaging is often reassuring. Your clinician interprets the whole picture, not the number alone.⁵⁸

CA-125 is not a general screening test

It is tempting to think regular CA-125 tests could catch ovarian cancer early. The large UK trial UKCTOCS tested exactly that: more than 200,000 postmenopausal women, followed for about 16 years, screened with CA-125 (interpreted by an algorithm) and/or ultrasound. The result: screening did not significantly reduce ovarian-cancer mortality. The authors concluded that population screening cannot be recommended.⁹ U.S. guidance agrees — MedlinePlus states plainly that CA-125 is "not used to screen healthy women."³ This is why CA-125 should be reserved for monitoring and diagnostic work-up, not ordered "just in case" in a woman without symptoms.

Benign causes of a high CA-125

Because CA-125 comes from serous membranes and reproductive tissue, many non-cancerous conditions push it up — most of them common in women. Frequent causes include:⁴⁵⁶

• Menstruation and pregnancy — physiologic, transient rises (highest in the first trimester).
• Endometriosis — a frequent cause of a raised CA-125, especially in advanced disease; the marker is even studied as a signal for this condition.⁶
• Ovarian cysts (particularly endometriomas), uterine fibroids, and adenomyosis.
• Pelvic inflammatory disease (PID) and other pelvic or peritoneal inflammation, including after abdominal surgery.⁴
• Non-gynecologic causes — cirrhosis, ascites, heart failure, and other conditions that irritate the peritoneum, pleura, or pericardium.⁵

In other words, anything that stretches or inflames a serous membrane can raise CA-125 without any cancer being present. This is also why the test is more reliable after menopause, when these benign gynecologic causes are far less common.² Tell your clinician if you are menstruating, pregnant, or have known endometriosis or cysts — each changes how the result is read.

CA-125 in ovarian cancer: monitoring and pelvic masses

CA-125 is raised mainly in epithelial ovarian cancer, where it has two well-established roles:

• Monitoring known disease. In a woman already diagnosed, the trend in CA-125 helps judge response to treatment and flag a recurrence. This is its best-validated use, even though its sensitivity has limits.¹⁰¹
• Evaluating a pelvic mass. Paired with HE4 in the ROMA score (which also factors in menopausal status), CA-125 helps estimate whether a pelvic mass is likely malignant and whether to refer to a gynecologic oncologist. ROMA performs at least as well as either marker alone for distinguishing benign from malignant masses.⁷⁸

Crucially, these decisions rest on transvaginal ultrasound and specialist assessment, with the marker as one input among several — never the deciding factor.¹¹⁸ A suspicious mass, a high or rising CA-125, or worrying symptoms warrant referral for imaging and gynecologic evaluation, investigated step by step rather than with alarm.

What can raise CA-125 (besides ovarian cancer)

Several factors move CA-125 independently of any cancer: the menstrual cycle, pregnancy, endometriosis, ovarian cysts and fibroids, pelvic infection or inflammation, ascites, cirrhosis, heart failure, and recent abdominal surgery.⁵⁶ Because peritoneal irritation drives it, even non-gynecologic inflammation can register — which is why a raised inflammatory marker such as CRP or an abnormal liver marker such as ALT (in cirrhosis with ascites) can accompany a high CA-125. Menopausal status also shapes interpretation, since benign causes are more frequent before menopause.² Share all of this with your clinician — it can completely change the reading of the result. As with other tumor markers such as PSA in men, CEA, or AFP, the story around the number matters as much as the number itself.

Recent research

According to recent PubMed publications and clinical-trial data:

• Population screening does not save lives. Long-term follow-up of the UKCTOCS trial confirmed that screening postmenopausal women with CA-125 and/or ultrasound does not reduce ovarian-cancer mortality, so it should not be offered to the general population.⁹
• Combining markers better triages a mass. The ROMA score (CA-125 + HE4, with menopausal status) improves the distinction between benign masses and ovarian cancer versus either marker alone, helping route patients to specialist centers.⁷⁸
• Beyond CA-125: liquid biopsies. Researchers are exploring finer blood markers (circulating tumor DNA and cells) to address the limits of CA-125 in early detection and monitoring; these remain research-stage approaches.¹²
• Useful outside oncology, too. Recent work highlights CA-125 as a marker of congestion (ascites, effusions, heart failure) — a reminder of how non-specific its elevation is for cancer.⁵

These findings concern monitoring and diagnosis; they do not authorize self-treatment and do not replace your physician's advice.

Get your CA-125 interpreted by AI DiagMe

A CA-125 is never read alone: its meaning depends on your age, your cycle (menstruation, pregnancy), any endometriosis or cyst, the imaging, and — in a known cancer — how it moves over time. A high CA-125 does not equal ovarian cancer. That cross-referencing is what gives the result its real value.

👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.

Frequently asked questions

Bottom line

The CA-125 blood test is a monitoring marker, not a screening tool: it is used mainly to track a known ovarian cancer and to help evaluate a pelvic mass (often with HE4, via the ROMA score, alongside ultrasound). Remember the usual reference (< 35 U/mL, lab-dependent, higher during menstruation and pregnancy), and above all that a high CA-125 is not a cancer diagnosis: benign causes — endometriosis, cysts, fibroids, menstruation, pregnancy, ascites, heart failure — are very common, especially in younger women, and the test is more reliable after menopause. Population screening does not save lives (UKCTOCS) and is not recommended. No value is read alone: it is your full picture — age, cycle, imaging, and trend — that counts, which is what AI DiagMe provides, alongside your physician.

Sources

Official sources and peer-reviewed publications (PubMed, ClinicalTrials.gov) used for this guide: